Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in Southwest Nigeria

AIDS Patient Care and STDs

Volumn 27, Issue 1, 2013, Pages 55-64

  Okoror, Titilayo A ^a   Falade, Catherine O ^b   Olorunlana, Adetayo ^b   Walker, Ebunlomo M ^c   Okareh, Oladapo T ^b  

^a BINGHAMTON UNIVERSITY   (United States)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c Initiative for Integrated Community Welfare in Nigeria (IICWIN)   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; AUDIO RECORDING; CLINICAL ARTICLE; CONCEPTUAL FRAMEWORK; CULTURAL FACTOR; FAMILY; FEMALE; FRIEND; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; LIFESTYLE; MALE; NIGERIA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERSONAL APPEARANCE; PERSONAL EXPERIENCE; SELF CONCEPT; SELF REPORT; SOCIAL ISOLATION; SOCIAL STIGMA; THEMATIC ANALYSIS;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTI-RETROVIRAL AGENTS; CULTURE; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NIGERIA; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITATIVE RESEARCH; SOCIAL STIGMA; STEREOTYPING; TAPE RECORDING; YOUNG ADULT;

EID: 84872279383     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0150     Document Type: Article

References (49)

1. TheWorld Bank. Nigeria: Country Brief 2011: World Bank, 2011.
2. USAID. HIV/AIDS Health Profile 2010. Washington DC: USAID, 2010.
3. UNAIDS. Global AIDS Epidemic Report. Geneva: UNAIDS, 2010.
4. Wong TWK, Ussher J. How do subjectively-constructed meanings ascribed to anti-HIV treatments affect treatmentadherent practice? Qual Health Res 2008;18:458-468.
5. Reynolds NR. Adherence to antiretroviral therapies: State of the science. Curr HIV Res 2004;2:207-214.
6. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006;43:939-941.
7. Maggiolo F, Ravasio L, Ripamonti D, et al. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis 2005;40:158-163.
8. Paterson DL, Swindell S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
9. Afolabi MO, Ijadunola KT, Fatusi AO, Olasode OA. Determinants of adherence to antiretroviral drugs among people living with HIV/AIDS in the Ife-Ijesa zone of Osun state, Nigeria. Afr J Prm Health Care Fam Med 2009;1:1-6.
10. Olowookere SA, Fatiregun AA, Akinyemi JO, Bamgboye AE, Osagbemi GK. Prevalence and determinants of nonadherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria. J Infect Dev Ctries 2008;2:369-372.
11. Habib AG, Shepherd JC, Eng MKL, et al. Adherence to antiretroviral therapy (ART) during Muslim Ramadan fasting. AIDS Behav 2009;13: 42-45.
12. Daniel OJ, Oladapo OT, Ogundahunsi OA, Fagbenro S, Ogun SA, Odusoga OA. Default from anti-retroviral treatment programme in Sagamu, Nigeria. Afr J Biomed Res 2008;11:221-224.
13. Erah PO, Arute JE. Adherence of HIV/AIDS patients to antiretroviral therapy in a tertiary health facility in Benin City. Afr J Pharm Pharmacol 2008;2:145-152.
14. Uzochukwu BSC, Onwujekwe OE, Onoka AC, Okoli C, Uguru NP, Chukwuogo OI. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health Policy Plan 2009;24:189-196.
15. Nwauche CA, Erhabor O, Ejele OA, Akani CI. Adherence to antiretroviral therapy among HIV-infected subjects in a resource-limited setting in the Niger Delta of Nigeria. Afr J Health Sci 2006;13:13-17.
16. Mohammed MD, Sarki R. Adherence to antiretroviral drugs in North-Central zone of Nigeria. East Central African J Pharmaceut Sci 2004;7:52-55.
17. Monjok E, Smesny A, Essien EJ. HIV/AIDS-Related stigma and discrimination in Nigeria: Review of research studies and future directions for prevention strategies. Afr J Reprod Health 2009;13:21-35.
18. Deacon H. Understanding HIV/AIDS Stigma. A Theoretical and Methodological Analysis. Cape Town: HSRC Press, 2005.
19. Okoror TA, Airhihenbuwa CO, Shisana O, et al. "My mother told me I must not cook anymore"-Food, culture, and the contexts of HIV and AIDS related stigma in three communities in South Africa. Int Q Community Health Educ 2008;28: 201-213.
20. Maughan-Brown B. Stigma rises despite antiretroviral rollout: A longitudinal analysis in South Africa. Soc Sci Med 2010;70:368-374.
21. Roura M, Urassa M, Busza J, Mbata D, Wringe A, Zaba A. Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania. Sex Transm Infect 2008;85:308-312.
22. Atuyambe L, Neema S, Otolok-Tanga E, Wamuyu-Maina G, Kasasa S, Wabwire-Mangen F. The effects of enhanced access to antiretroviral therapy: A qualitative study of community perceptions in Kampala city, Uganda. Afr Health Sci 2008;8:13-19.
23. Wolfe WR, Weiser SD, Bangsberg DR, et al. Effects of HIVrelated stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care 2006;18: 931-933.
24. Gilbert L, Walker L. "My biggest fear was that people would reject me once they know my status.": stigma as experienced by patients in an HIV/AIDS clinic in Johannesburg, South Africa. Health Soc Care Commu 2010;18:139-146.
25. Adedimeji AA, Omololu FO, Odutolu O. HIV risk perception and constraints to protective behavior among young slum dwellers in Ibadan, Nigeria. J Health Popul Nutr 2007;25:146-157.
26. Orubuloye IO, Caldwell P, Caldwell JC. The role of high-risk occupations in the spread of AIDS: Truck drivers and itinerant market women in Nigeria. Int Perspect Sex Reprod Health 1993;19: 43-48.
27. Nigerian National Population Census. 2006. http://www .population.gov.ng/index.php?option = com-content&view= article&id = 89. Date of last online access: July 20, 2011.
28. National Agency for the Control of AIDS (NACA). Federal Republic of Nigeria Global AIDS Response: Country Progress Report Nigeria GARPR 2012. http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/ 2012countries/Nigeria%202012%20GARPR%20Report%20 Revised.pdf Date of last online access: October 10, 2012.
29. Patton MQ. Qualitative Research and Evaluation Methods. Thousand Oaks CA: Sage, 2002.
30. Denzin NK, Lincoln YS. The Sage Handbook on Qualitative Research. Thousand Oaks, CA: Sage, 2011.
31. Schwandt TA. Constructivist, interpretivist approaches to human inquiry. In: The Landscape of Qualitative Research: Theories and Issues. California: Sage,1998.
32. Creswell JW. Research Design: Qualitative, Quantitative and Mixed Methods Approaches. Thousand Oaks, CA: Sage, 2003.
33. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77-101.
34. Boyatzis RE. Transforming Qualitative Information: Thematic Analysis and Code Development. Thousand Oaks, California: Sage, 1998.
35. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. J Acquir Immune Defic Syndr 1998;18:80-85.
36. Rosenbrock R, Dubois-Arber F, Moers M, Pinell P, Schaffer D, Setbon M. The normalization of AIDS in Western European countries. Soc Sci Med 2000;50:1607-1629.
37. Ware NC, Idoko J, Kaaya S, et al. Explaining adherence success in sub-Saharan Africa: An ethnographic study. PLoS Med 2009;6: e1000011.doi:10. 1371/journal.pmed.1000011.
38. van Griensven J, Zachariah R, Mugabo J, Reid T. Weight loss after the first year of stavudine-containing antiretroviral therapy and its association with lipoatrophy, virological failure, adherence and CD4 counts at primary health care level in Kigali, Rwanda. Trans R Soc Trop Med Hyg 2010;104:751-757.
39. Pujari SN, Dravid A, Naik E, et al. Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India. J Acquir Immue Defic Syndr 2005;39:199-202.
40. Li X, Huang L, Wang H, et al. Stigma mediates the relationship between self-efficacy, medication adherence, and quality of life among people living with HIV/AIDS in China. AIDS Patient Care STDS 2011;25:665-671.
41. Dageid W, Duckert F. Balancing between normality and social death: Black, rural, South African women coping with HIV/AIDS. Qual Health Res 2008;18:182-195.
42. Nzokia C. The social meanings of death from HIV/AIDS: An African interpretative view. Cult Health Sex 2000;2:1-14.
43. Calin T, Green J, Hetherton J, Brook G. Disclosure of HIV among black African men and women attending a London HIV clinic. AIDS Care 2007;19:385-391.
44. Skogmar S, Shakely D, Lans M, et al. Effect of antiretroviral treatment and counseling on disclosure of HIV-serostatus in Johannesburg, South Africa. AIDS Care 2006;18:725-730.
45. Uys L, Chirwa M, Kohi, et al. Evaluation of a health settingbased stigma intervention in five African countries. AIDS Patient Care STDS 2009;23:1059-1066.
46. Smith DJ, Mbakwem BC. Life projects and therapeutic itineraries: Marriage, fertility and antiretroviral therapy in Nigeria. AIDS 2007;21:S37-41.
47. Carr RL, Gramling LF. Stigma: A health barrier for women with HIV/AIDS. J Assoc Nurses AIDS Care 2004;15:30-39.
48. Smith DJ. Modern marriage, men's extramarital sex, and HIV risk in Southeastern Nigeria. Am J Public Health 2007; 97:997-1005.
49. Mane P, Aggleton P. "Gender and HIV/AIDS: What Do Men Have to Do with It?" Curr Soc 2001;49:23-37.